Senexis is a growing, small-molecule drug development company that is committed to revolutionising the treatment of diseases resulting from the inevitable process of ageing. Senexis is advancing a pipeline of novel treatments for diseases resulting from the toxicity of amyloid-like proteins. Our pipeline is currently focused on discovering therapies for the treatment of Alzheimer's disease.
Company Details
- Founded
- -
- Address
- Babraham Research Campus, Cambridge,cb22 3at,united Kingdom
- Phone
- +44 1223 496 160
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- senexis.com
- Keywords
- Research and Development, R&D, CNS.
- HQ
- Cambridge
Senexis Limited Questions
Senexis Limited's helpline number is +44 1223 496 160
Senexis Limited's website is senexis.com
Senexis Limited's LinkedIn profile is https://uk.linkedin.com/company/senexis-limited
Senexis Limited's industry is
Pharmaceutical Manufacturing
Senexis Limited's top competitors are
Safran,
Mycural Therapeutics,
Sprint Bioscience,
Amporin Pharmaceuticals,
Merck Healthcare,
Thales.
Senexis Limited's categories are Pharmaceutical Manufacturing
Senexis Limited's founding year is 2001
